Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

scientific article published in August 2002

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/SYN.10090
P698PubMed publication ID12112405
P5875ResearchGate publication ID11266973

P50authorDavid EidelbergQ5233311
Yilong MaQ38320617
Vijay DhawanQ48359296
Phoebe G SpetsierisQ58825556
Thomas ChalyQ66724649
P2093author name stringMentis M
P433issue2
P921main subjectParkinson's diseaseQ11085
P304page(s)125-133
P577publication date2002-08-01
P1433published inSynapseQ7662025
P1476titleParametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study
P478volume45

Reverse relations

cites work (P2860)
Q4825494618F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages
Q9258418318F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
Q90049662A Fully Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images
Q33835425Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease
Q45125241Assessment of disease progression in parkinsonism
Q98177376Brain Metabolisms Involved in Self-Reported Quality of Mobility in Parkinson's Disease
Q35679748Changes in network activity with the progression of Parkinson's disease
Q38829876Comparison of the Performances of (18)F-FP-CIT Brain PET/MR and Simultaneous PET/CT: a Preliminary Study
Q48189018Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Q53271583Correlation between focal brain metabolism and higher brain function in patients with Moyamoya disease.
Q35539231Dopaminergic striatal innervation predicts interlimb transfer of a visuomotor skill
Q33967306Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.
Q35683827Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image
Q33700944Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's Disease
Q37706110Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine
Q35863417Functional imaging in Parkinson's disease and dementia with Lewy bodies
Q35552960How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease?
Q43076413Imaging essential tremor
Q44538116Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible
Q48591966Impact of regional striatal dopaminergic function on kinematic parameters of Parkinson's disease.
Q40499580Is Dominant-Side Onset Associated With a Better Motor Compensation in Parkinson's Disease?
Q38119449L-DOPA and graft-induced dyskinesia: different treatment, same story?
Q48829872Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations
Q42447408Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.
Q30989947Neuroimaging and therapeutics in movement disorders
Q36901626Parkinson's disease cognitive network correlates with caudate dopamine
Q33644318Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum
Q48326947Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography
Q33851458Radiosynthesis and validation of ¹⁸F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain.
Q44740907Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET.
Q37812319Role of glial cells in neurotoxin-induced animal models of Parkinson's disease
Q38736125Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
Q36561279The assessment of neurological systems with functional imaging
Q41829532The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study
Q38166969Tropane-derived (11) C-labelled and (18) F-labelled DAT ligands
Q33704640Validation of Simple Quantification Methods for (18)F-FP-CIT PET Using Automatic Delineation of Volumes of Interest Based on Statistical Probabilistic Anatomical Mapping and Isocontour Margin Setting

Search more.